Using Virtual Reality to Reduce Sedation During Endoscopy
Official title: Pilot Proof of Concept Study for Implementing Virtual Reality (VR) to Reduce Sedation Requirement During Endoscopy
Run by NYU Langone Health · NCT06349564 · Data updated 2026-11-12
This study is testing if using Virtual Reality during endoscopy can help adults feel more comfortable with less sedation and recover faster.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (Brooklyn, New York) |
| Status | Recruiting |
| Started | December 9, 2024 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT06349564 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia.
✕Probably not a fit
Patients with visual impairments, a history of cardiovascular disease, seizures, vertigo, allergies to plastic, or active gastrointestinal bleeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves patients aged 21 to 65 who are undergoing screening colonoscopy or diagnostic upper endoscopy for conditions like GERD or dyspepsia. Participants will receive minimal sedation while wearing Virtual Reality (VR) goggles throughout the procedure. The aim is to evaluate the feasibility, effects, and safety of VR in reducing sedation needs, improving patient satisfaction, and shortening recovery time. The intervention utilizes a Pico 4 Enterprise headset with noise-cancelling headphones.
Why it matters
Potential benefit: If successful, this approach could lead to less sedation required during endoscopic procedures, enhancing patient comfort and recovery.
How similar studies have gone: While the use of VR in medical settings is gaining interest, this specific application for reducing sedation during endoscopy is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
INTERVENTION GROUP Inclusion Criteria: * Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital * Aged 21 to 65 Exclusion Criteria: * Visual impairments such as blindness which would impair them from watching the entertainment videos. * Patients with history of CAD, * History of seizures, * History of vertigo, * History of allergy to plastic, * ASAII or III, * Patient with active GI bleed, having either melena or hematochezia. CONTROL GROUP Inclusion Criteria: * Underwent screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital * Aged 21 to 65 Exclusion Criteria: * Visual impairments such as blindness which would impair them from watching the entertainment videos * Patients with history of CAD * History of seizures * History of vertigo * History of allergy to plastic * ASAII or III * Patient with active GI bleed, having either melena or hematochezia
Where it's running
-
NYU Langone Brooklyn
Brooklyn, New York, United States Recruiting
Study contacts
- Principal investigator: Maysaa El Zoghbi, MD — NYU Langone Health
- Study coordinator: Maysaa El Zoghbi, MD
- Email: Maysaa.ElZoghbi@nyulangone.org
- Phone: 216-835-7626
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial unloader brace after root repair
This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.
-
MAC-STILA: a feasibility test for hip fracture surgery anesthesia
This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.
-
Osimertinib with Cyclosporine A for EGFR-mutant NSCLC
This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.
-
Histotripsy with chemotherapy and immunotherapy for biliary tract cancer
This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
Virtual Reality Vision Testing for Metamorphopsia and Aniseikonia
A portable virtual reality headset is tested to see if it can more reliably and conveniently measure visual distortions in people with metamorphopsia or aniseikonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.